Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 318

1.

Admission wall motion score and quantitative ST-segment depression in the assessment of 30-day mortality in patients with first non-ST-segment elevation acute coronary syndromes.

Figueras J, Barrabés JA, Evangelista A, Lidón RM, Gutierrez L, Garcia del Blanco B, Garcia-Dorado D.

J Am Soc Echocardiogr. 2013 Aug;26(8):885-92. doi: 10.1016/j.echo.2013.05.003. Epub 2013 Jun 19.

PMID:
23791114
2.

Assessment of the prognostic value of coronary angiography in patients with non-ST segment elevation myocardial infarction.

Maciejewski P, Lewandowski P, Wąsek W, Budaj A.

Kardiol Pol. 2013;71(2):136-42. doi: 10.5603/KP.2013.0006.

3.

Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes.

Savonitto S, Cohen MG, Politi A, Hudson MP, Kong DF, Huang Y, Pieper KS, Mauri F, Wagner GS, Califf RM, Topol EJ, Granger CB.

Eur Heart J. 2005 Oct;26(20):2106-13. Epub 2005 Jun 29.

PMID:
15987706
4.
5.

Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial.

Planer D, Mehran R, Ohman EM, White HD, Newman JD, Xu K, Stone GW.

Circ Cardiovasc Interv. 2014 Jun;7(3):285-93. doi: 10.1161/CIRCINTERVENTIONS.113.000606. Epub 2014 May 20.

6.

NT-proBNP levels in patients with non-ST-segment elevation acute coronary syndrome.

Castro LR, Alencar MC, Barbosa MM, Nunes Mdo C, Cardoso JR, Ribeiro AL.

Arq Bras Cardiol. 2011 Dec;97(6):456-61. Epub 2011 Oct 27. English, Portuguese.

7.

Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.

Registro Osservazionale Angina Instabile Investigators.

Ital Heart J. 2003 Nov;4(11):782-90.

PMID:
14699708
9.

The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies.

de Lemos JA, Morrow DA, Gibson CM, Murphy SA, Sabatine MS, Rifai N, McCabe CH, Antman EM, Cannon CP, Braunwald E.

J Am Coll Cardiol. 2002 Jul 17;40(2):238-44.

11.

Mitral annular displacement by Doppler tissue imaging may identify coronary occlusion and predict mortality in patients with non-ST-elevation myocardial infarction.

Zahid W, Johnson J, Westholm C, Eek CH, Haugaa KH, Smedsrud MK, Skulstad H, Fosse E, Winter R, Edvardsen T.

J Am Soc Echocardiogr. 2013 Aug;26(8):875-84. doi: 10.1016/j.echo.2013.05.011. Epub 2013 Jun 19.

PMID:
23791116
12.

Prognostic value of clinical variables at presentation in patients with non-ST-segment elevation acute coronary syndromes: results of the Proyecto de Estudio del Pronóstico de la Angina (PEPA).

López de Sá E, López-Sendón J, Anguera I, Bethencourt A, Bosch X; Proyecto de Estudio del Pronostico de la Angina (PEPA) Investigators.

Medicine (Baltimore). 2002 Nov;81(6):434-42.

13.

Association among leukocyte count, mortality, and bleeding in patients with non-ST-segment elevation acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial).

Palmerini T, Généreux P, Mehran R, Dangas G, Caixeta A, Riva DD, Mariani A, Xu K, Stone GW.

Am J Cardiol. 2013 May 1;111(9):1237-45. doi: 10.1016/j.amjcard.2012.12.056. Epub 2013 Feb 11.

PMID:
23411106
14.

ST-segment elevation in lead aVR in the setting of acute coronary syndrome.

Nabati M, Emadi M, Mollaalipour M, Bagheri B, Nouraei M.

Acta Cardiol. 2016 Feb;71(1):47-54. doi: 10.2143/AC.71.1.3132097.

PMID:
26853253
15.

Influence of presenting electrocardiographic findings on the treatment and outcomes of patients with non-ST-segment elevation myocardial infarction.

Patel JH, Gupta R, Roe MT, Peng SA, Wiviott SD, Saucedo JF.

Am J Cardiol. 2014 Jan 15;113(2):256-61. doi: 10.1016/j.amjcard.2013.09.009. Epub 2013 Oct 2.

PMID:
24290492
16.

Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.

Eren NK, Ertaş F, Yüksek U, Cakir C, Nazli C, Köseoğlu M, Ergene O.

Turk Kardiyol Dern Ars. 2009 Jan;37(1):1-8.

17.

Relation of T-wave alternans to mortality and nonsustained ventricular tachycardia in patients with non-ST-segment elevation acute coronary syndrome from the MERLIN-TIMI 36 trial of ranolazine versus placebo.

Nieminen T, Scirica BM, Pegler JR, Tavares C, Pagotto VP, Kanas AF, Sobrado MF, Nearing BD, Umez-Eronini AA, Morrow DA, Belardinelli L, Verrier RL.

Am J Cardiol. 2014 Jul 1;114(1):17-23. doi: 10.1016/j.amjcard.2014.03.056. Epub 2014 Apr 16.

PMID:
24852915
18.
19.

A risk score to predict bleeding in patients with acute coronary syndromes.

Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, Parise H, Fahy M, Manoukian SV, Feit F, Ohman ME, Witzenbichler B, Guagliumi G, Lansky AJ, Stone GW.

J Am Coll Cardiol. 2010 Jun 8;55(23):2556-66. doi: 10.1016/j.jacc.2009.09.076.

20.

Prolonged QT interval in ST-elevation myocardial infarction and mortality: new prognostic scale with QT, Killip and age.

Rivera-Fernández R, Arias-Verdú MD, García-Paredes T, Delgado-Rodríguez M, Arboleda-Sánchez JA, Aguilar-Alonso E, Quesada-García G, Vera-Almazán A.

J Cardiovasc Med (Hagerstown). 2016 Jan;17(1):11-9. doi: 10.2459/JCM.0000000000000015.

PMID:
24922196

Supplemental Content

Support Center